Last week, the FDA issued an announcement recalling multiple kinds of frozen fruit by Willamette Valley Fruit Co. The company is recalling the Great Value sliced strawberries, mixed fruit, and...
On June 12, 2023, United States Food and Drug Administration officials provided guidance for reducing microbial contamination in tattoo ink. The draft recommendation, now open for public commentary,...
Although drug-checking tools such as fentanyl test strips have been championed as critical harm-reduction tools in the opioid epidemic, additional data and research are required to assess their...
Biosimilar adoption by the healthcare industry can incentivize pharmaceutical development and increase options for patients, payers, and providers by offering a less expensive alternative to biologic...
As the inflation rate continues to rise, the healthcare industry — like every other industry — is taxed with extraordinarily high costs. Rising drug prices have caused increased healthcare expenditures and out-of-pocket costs....
In a statement issued on May 24, 2023, Qilu Pharmaceutical Co, a Chinese pharmaceutical company, will export cisplatin, a chemotherapy drug, to the United States. Amidst shortages that began in early...
As the healthcare industry continues to embrace artificial intelligence (AI), experts are examining the challenges that hamstring the adoption of this transformative technology.
Understanding the challenges and potential of...
On May 30, 2023, the United States Food and Drug Administration (FDA) proposed an additional Patient Medication Information (PMI) section on human prescription drug labels, amending current...
Compounded forms of semaglutide have been linked to adverse events, leading to FDA-issued warnings. As a result, the FDA recommends that patients avoid compounded semaglutide whenever the approved...
Gaining popularity from celebrity endorsements and public speculation, Ozempic has become a staple weight loss drug in the United States. However, researchers speculate that the medication could...
On May 22, 2023, the FDA approved Opvee, a nalmefene hydrochloride nasal spray that can reverse an opioid overdose in patients 12 and older. This approval adds a harm-reduction tool to existing tools,...
On May 19, 2023, the CDC released an update on the Pseudomonas aeruginosa outbreak linked to artificial tears from Global Pharma Healthcare. The report identifies a fourth death linked to the series of...
On May 11, 2023, the United States FDA Pulmonary–Allergy Drug Advisory Committee (PADAC) favored the approval of Neffy, the first intranasal epinephrine spray for allergic reactions. The panel...
After months of deliberation and review, the FDA has finally expanded its blood donor eligibility by adjusting its donation guidelines. Joining other developed nations, including the United Kingdom and...
In April, the United States Food and Drug Administration (USFDA) announced a shortage of injectable penicillin, penicillin G benzathine, adding to the never-ending list of medications with supply chain...
JAMA recently published a research letter highlighting the lack of supplement regulation by comparing the amount of melatonin and CBD in varying brands of melatonin gummies. The researchers determined...
Yesterday, the FDA published a copy of its draft guidance for decentralized clinical trials, adding to previously issued guidelines. Clinical trial participants may be able to bring trials to their...
According to research from the Atlantic Council, pharmaceutical products have become a valuable part of the United States and China’s trading relationship, growing from 0.6% of the total trade to...
The FDA recently approved Omisirge (omidubicel-onlv), a new cell therapy meant to protect patients with blood cancer after a stem cell transplant. According to the press release, the treatment can...
On April 18, 2023, the FDA issued an announcement, updating the emergency use authorization (EUA) for the bivalent mRNA COVID-19 vaccines. Attempting to simplify use for healthcare professionals, the...
